PubmedID,Title,Publication Date,Non-academic Author(s),Company Affiliation(s),Corresponding Author Email
40184571,Lines of Therapy for Locally Advanced/Metastatic Urothelial Carcinoma: The New Paradigm.,2025 Apr 4,Abidoye O; Jain P; Singh P,,N/A
40184365,Findings from a qualitative analysis: Social media influencers of color as trusted messengers of HPV vaccination messages.,2025,Sustaita-Ruiz A,,N/A
40184324,Effects of cannabinoids on immune checkpoint inhibitor response: CCTG pooled analysis of individual patient data.,2025 Apr 4,Coschi CH; Ding K; Tong J; Tu D; O'Callaghan C; Vera-Badillo F; Seymour L; Renouf DJ; Chen E; Gaudreau PO,"Princess Margaret Cancer Centre, Toronto, ON, Canada.",N/A
40183901,Outcomes of concurrent versus non-concurrent immune checkpoint inhibition with stereotactic radiosurgery for melanoma brain metastases.,2025 Apr 4,Oermann EK,,N/A
40183852,"Lessons learned from a decade of immune checkpoint inhibition: The good, the bad, and the ugly.",2025 Apr 4,Kurzrock R,,N/A
40183827,In vitro and in vivo evaluation of anti-HER2 antibody conjugates labelled with (225)Ac.,2025 Apr 4,Bruchertseifer F; Morgenstern A,,N/A
40183381,Analysis of pembrolizumab in microsatellite instability high (MSI-H) and deficient mismatch repair (dMMR) non-colorectal patients with metastatic cancer.,2025 Apr 4,Tandyk A,"Rush MD Anderson Cancer Center Pharmacy, Chicago, USA.",N/A
40183219,Real-world data of immune-related adverse events in lung cancer patients receiving immune-checkpoint inhibitors.,2025 Apr 4,Hu X; Lin JH; Parsons SK,,N/A
